American Century Companies Inc. raised its holdings in LifePoint Health, Inc. (NASDAQ:LPNT) by 7.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,630,487 shares of the company’s stock after buying an additional 260,944 shares during the quarter. American Century Companies Inc. owned approximately 9.05% of LifePoint Health worth $210,205,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of LPNT. Stevens Capital Management LP acquired a new position in LifePoint Health during the 3rd quarter worth approximately $1,395,000. Hussman Strategic Advisors Inc. acquired a new position in shares of LifePoint Health in the 3rd quarter valued at approximately $1,517,000. Parametrica Management Ltd acquired a new position in shares of LifePoint Health in the 3rd quarter valued at approximately $282,000. Victory Capital Management Inc. raised its position in shares of LifePoint Health by 19.3% in the 3rd quarter. Victory Capital Management Inc. now owns 973,978 shares of the company’s stock valued at $56,393,000 after purchasing an additional 157,831 shares in the last quarter. Finally, First Quadrant L P CA acquired a new position in shares of LifePoint Health in the 3rd quarter valued at approximately $5,043,000. Institutional investors own 99.18% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Week Herald and is owned by of Week Herald. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://weekherald.com/2017/11/17/lifepoint-health-inc-lpnt-shares-bought-by-american-century-companies-inc.html.
Shares of LifePoint Health, Inc. (NASDAQ LPNT) traded up $0.55 during trading on Friday, reaching $44.10. The company had a trading volume of 392,000 shares, compared to its average volume of 419,670. The stock has a market cap of $1,730.00, a P/E ratio of 11.11, a P/E/G ratio of 1.13 and a beta of 0.68. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.65 and a current ratio of 1.85. LifePoint Health, Inc. has a 1 year low of $42.50 and a 1 year high of $70.95.
LifePoint Health (NASDAQ:LPNT) last issued its earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the consensus estimate of $0.95 by ($0.15). LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.60 billion. During the same period in the previous year, the company earned $0.94 earnings per share. The business’s revenue for the quarter was down .7% on a year-over-year basis. research analysts forecast that LifePoint Health, Inc. will post 3.65 earnings per share for the current year.
LifePoint Health declared that its Board of Directors has approved a share buyback plan on Friday, October 27th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Shares buyback plans are often an indication that the company’s board believes its stock is undervalued.
A number of brokerages have recently weighed in on LPNT. ValuEngine downgraded LifePoint Health from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Zacks Investment Research upgraded LifePoint Health from a “sell” rating to a “hold” rating in a report on Monday, September 11th. Credit Suisse Group started coverage on LifePoint Health in a research note on Thursday, November 2nd. They set a “neutral” rating and a $54.00 price objective for the company. SunTrust Banks, Inc. set a $60.00 price objective on LifePoint Health and gave the stock a “hold” rating in a research note on Thursday, October 12th. Finally, Piper Jaffray Companies restated a “hold” rating and set a $66.00 price objective on shares of LifePoint Health in a research note on Wednesday, October 4th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $60.23.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.